Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Capricor Therapeutics, Inc. (CAPR) since 2008 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Capricor Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1133869.
Total stock buying since 2008: $30,411,479.
Total stock sales since 2008: $949,416,646.
Total stock option exercises since 2008: $1,138,090.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 29,000 | $40,308 |
| 2024 | 2,798,507 | $14,999,997 | 0 | $0 | 108,547 | $144,966 |
| 2023 | 22,993 | $65,211 | 17,772 | $949,231,355 | 146,696 | $379,421 |
| 2022 | 2,500 | $9,323 | 45,990 | $185,291 | 243,085 | $337,885 |
| 2021 | 0 | $0 | 0 | $0 | 35,846 | $44,628 |
| 2020 | 0 | $0 | 0 | $0 | 49,796 | $184,244 |
| 2017 | 1,180,161 | $3,658,499 | 0 | $0 | 41,496 | $6,638 |
| 2016 | 1,772,209 | $4,503,299 | 0 | $0 | 0 | $0 |
| 2015 | 2,007,254 | $7,109,330 | 0 | $0 | 0 | $0 |
| 2012 | 275,000 | $0 | 0 | $0 | 0 | $0 |
| 2010 | 50,000 | $0 | 0 | $0 | 0 | $0 |
| 2009 | 311,904 | $8,752 | 0 | $0 | 0 | $0 |
| 2008 | 48,280 | $57,068 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-03 | 0 | $0 | 0 | $0 | 28,250 | $39,266 |
| 2025-02 | 0 | $0 | 0 | $0 | 750 | $1,042 |
| 2024-12 | 0 | $0 | 0 | $0 | 28,391 | $33,550 |
| 2024-09 | 2,798,507 | $14,999,997 | 0 | $0 | 0 | $0 |
| 2024-08 | 0 | $0 | 0 | $0 | 34,000 | $47,260 |
| 2024-04 | 0 | $0 | 0 | $0 | 46,156 | $64,156 |
| 2023-10 | 22,993 | $65,211 | 0 | $0 | 2,178 | $3,027 |
| 2023-08 | 0 | $0 | 0 | $0 | 20,748 | $28,839 |
| 2023-05 | 0 | $0 | 0 | $0 | 20,749 | $28,841 |
| 2023-04 | 0 | $0 | 14,772 | $949,219,176 | 84,791 | $293,376 |
| 2023-03 | 0 | $0 | 3,000 | $12,179 | 0 | $0 |
| 2023-02 | 0 | $0 | 0 | $0 | 18,230 | $25,338 |
| 2022-11 | 0 | $0 | 0 | $0 | 18,932 | $26,315 |
| 2022-07 | 1,000 | $3,680 | 0 | $0 | 0 | $0 |
| 2022-06 | 1,500 | $5,643 | 45,990 | $185,291 | 10,796 | $15,006 |
| 2022-03 | 0 | $0 | 0 | $0 | 58,814 | $81,750 |
| 2022-01 | 0 | $0 | 0 | $0 | 154,543 | $214,814 |
| 2021-12 | 0 | $0 | 0 | $0 | 35,846 | $44,628 |
| 2020-09 | 0 | $0 | 0 | $0 | 8,299 | $30,706 |
| 2020-07 | 0 | $0 | 0 | $0 | 41,497 | $153,538 |
| 2017-12 | 0 | $0 | 0 | $0 | 20,748 | $3,319 |
| 2017-10 | 0 | $0 | 0 | $0 | 20,748 | $3,319 |
| 2017-05 | 1,180,161 | $3,658,499 | 0 | $0 | 0 | $0 |
| 2016-09 | 312,500 | $1,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-03 | Bergmann Anthony (CHIEF FINANCIAL OFFICER) | Option Ex | 2,500 | 1.39 | 3,474 |
| 2025-03-03 | Litvack Frank | Option Ex | 25,000 | 1.39 | 34,750 |
| 2025-03-03 | Dunbar George W Jr | Option Ex | 750 | 1.39 | 1,042 |
| 2025-02-27 | Collier Earl M Jr | Option Ex | 750 | 1.39 | 1,042 |
| 2024-12-13 | Krasney Karen (EVP, GENERAL COUNSEL) | Option Ex | 8,000 | 1.39 | 11,120 |
| 2024-12-03 | Litvack Frank | Option Ex | 20,391 | 1.10 | 22,430 |
| 2024-09-20 | Nippon Shinyaku Co Ltd | Buy | 2,798,507 | 5.36 | 14,999,997 |
| 2024-08-07 | Musket David B | Option Ex | 34,000 | 1.39 | 47,260 |
| 2024-04-23 | Musket David B | Option Ex | 16,156 | 1.39 | 22,456 |
| 2024-04-23 | Collier Earl M Jr | Option Ex | 30,000 | 1.39 | 41,700 |
| 2023-10-23 | Bergmann Anthony (CHIEF FINANCIAL OFFICER) | Option Ex | 2,178 | 1.39 | 3,027 |
| 2023-10-12 | Musket David B | Buy | 410 | 2.75 | 1,127 |
| 2023-10-10 | Collier Earl M Jr | Buy | 10,000 | 2.83 | 28,300 |
| 2023-10-09 | Musket David B | Buy | 5,083 | 2.82 | 14,334 |
| 2023-10-06 | Auwaerter Paul Gisbert | Buy | 5,000 | 2.84 | 14,200 |
| 2023-10-04 | Musket David B | Buy | 2,500 | 2.90 | 7,250 |
| 2023-08-14 | Litvack Frank | Option Ex | 20,748 | 1.39 | 28,839 |
| 2023-05-12 | Marban Linda (CHIEF EXECUTIVE OFFICER) | Option Ex | 20,749 | 1.39 | 28,841 |
| 2023-04-17 | Avat Xavier (Other) | Sale | 14,772 | 64,258.00 | 949,219,176 |
| 2023-04-05 | Avat Xavier | Option Ex | 84,791 | 3.46 | 293,376 |
| 2023-03-28 | Avat Xavier | Sale | 3,000 | 4.06 | 12,179 |
| 2023-02-21 | Manzo Louis | Option Ex | 1,401 | 1.39 | 1,947 |
| 2023-02-21 | Litvack Frank | Option Ex | 14,027 | 1.39 | 19,497 |
| 2023-02-14 | Collier Earl M Jr | Option Ex | 1,401 | 1.39 | 1,947 |
| 2023-02-14 | Dunbar George W Jr | Option Ex | 1,401 | 1.39 | 1,947 |
| 2022-11-03 | Krasney Karen (EVP, GENERAL COUNSEL) | Option Ex | 18,932 | 1.39 | 26,315 |
| 2022-07-06 | Avat Xavier (CHIEF BUSINESS OFFICER) | Buy | 1,000 | 3.68 | 3,680 |
| 2022-06-30 | Musket David B | Option Ex | 10,796 | 1.39 | 15,006 |
| 2022-06-29 | Avat Xavier (CHIEF BUSINESS OFFICER) | Buy | 1,500 | 3.76 | 5,643 |
| 2022-06-29 | Musket David B | Sale | 28,215 | 3.77 | 106,370 |
| 2022-06-27 | Musket David B | Sale | 17,775 | 4.44 | 78,921 |
| 2022-03-31 | Manzo Louis | Option Ex | 27,904 | 1.39 | 38,786 |
| 2022-03-29 | Dunbar George W Jr | Option Ex | 15,455 | 1.39 | 21,482 |
| 2022-03-08 | Collier Earl M Jr | Option Ex | 15,455 | 1.39 | 21,482 |
| 2022-01-03 | Litvack Frank | Option Ex | 154,543 | 1.39 | 214,814 |
| 2021-12-27 | Musket David B | Option Ex | 35,846 | 1.25 | 44,628 |
| 2020-09-24 | Manzo Louis | Option Ex | 8,299 | 3.70 | 30,706 |
| 2020-07-27 | Marban Linda (CHIEF EXECUTIVE OFFICER) | Option Ex | 41,497 | 3.70 | 153,538 |
| 2017-12-22 | Smith Rachel (Vice President of R&D) | Option Ex | 20,748 | .16 | 3,319 |
| 2017-10-23 | Manzo Louis | Option Ex | 20,748 | .16 | 3,319 |
| 2017-05-09 | Manzo Louis | Buy | 10,000 | 3.10 | 31,000 |
| 2017-05-09 | Musket David B | Buy | 25,000 | 3.10 | 77,500 |
| 2017-05-09 | Cedars Sinai Medical Center | Buy | 1,145,161 | 3.10 | 3,549,999 |
| 2016-09-21 | Cedars Sinai Medical Center | Buy | 312,500 | 3.20 | 1,000,000 |
| 2016-03-16 | Edward St. John, Llc | Buy | 833,332 | 2.40 | 1,999,996 |
| 2016-03-16 | Manzo Louis | Buy | 100,000 | 2.40 | 240,000 |
| 2016-03-16 | Bergmann Anthony (Vice President of Finance) | Buy | 2,030 | 2.40 | 4,872 |
| 2016-03-16 | Krasney Karen (EVP, General Counsel) | Buy | 4,060 | 2.40 | 9,744 |
| 2016-03-16 | Marban Linda (Chief Executive Officer) | Buy | 10,152 | 2.40 | 24,364 |
| 2016-03-16 | Gershell Leland (CHIEF FINANCIAL OFFICER) | Buy | 2,100 | 2.40 | 5,040 |
| 2016-03-16 | Cedars Sinai Medical Center | Buy | 416,666 | 2.40 | 999,998 |
| 2016-03-16 | Grasmick Louis J | Buy | 91,369 | 2.40 | 219,285 |
| 2015-08-20 | Grasmick Louis J | Buy | 9,260 | 4.08 | 37,753 |
| 2015-08-19 | Marban Eduardo | Buy | 8,400 | 4.42 | 37,128 |
| 2015-08-19 | Marban Linda (Chief Executive Officer) | Buy | 8,400 | 4.42 | 37,128 |
| 2015-08-19 | Grasmick Louis J | Buy | 2,640 | 4.22 | 11,140 |
| 2015-08-18 | Marban Eduardo | Buy | 10,000 | 4.31 | 43,099 |
| 2015-08-18 | Marban Linda (Chief Executive Officer) | Buy | 10,000 | 4.31 | 43,099 |
| 2015-01-21 | Edward St. John, Llc | Buy | 851,546 | 3.52 | 2,999,996 |
| 2015-01-21 | Manzo Louis | Buy | 28,384 | 3.52 | 99,996 |
| 2015-01-21 | Krasney Karen (EVP, General Counsel) | Buy | 7,096 | 3.52 | 24,999 |
| 2015-01-21 | Musket David B | Buy | 70,962 | 3.52 | 249,999 |
| 2015-01-21 | Cedars Sinai Medical Center | Buy | 851,546 | 3.52 | 2,999,996 |
| 2015-01-21 | Grasmick Louis J | Buy | 141,924 | 3.52 | 499,998 |
| 2015-01-21 | Kazam Joshua A | Buy | 7,096 | 3.52 | 24,999 |
| 2012-03-30 | Lieu Hsiao (Executive VP, Clinical Dev.) | Buy | 12,500 | .00 | 0 |
| 2012-03-30 | Evans Daron (Chief Financial Officer) | Buy | 12,500 | .00 | 0 |
| 2012-03-30 | Kazam Joshua A (President & CEO) | Buy | 125,000 | .00 | 0 |
| 2012-03-30 | Brewer Richard B (Executive Chairman) | Buy | 125,000 | .00 | 0 |
| 2010-04-22 | Kazam Joshua A (Chief Executive Officer) | Buy | 50,000 | .00 | 0 |
| 2009-07-07 | Evans Daron (Chief Financial Officer) | Buy | 3,952 | .00 | 0 |
| 2009-07-07 | Kash Peter M (Director) | Buy | 98,814 | .00 | 0 |
| 2009-07-07 | Kazam Joshua A (Director) | Buy | 197,628 | .00 | 0 |
| 2009-03-13 | Evans Daron (Chief Financial Officer) | Buy | 5,000 | .75 | 3,750 |
| 2009-03-12 | Kazam Joshua A (Director) | Buy | 510 | .75 | 382 |
| 2009-03-11 | Evans Daron (Chief Financial Officer) | Buy | 6,000 | .77 | 4,620 |
| 2008-12-16 | Kazam Joshua A (Director) | Buy | 3,100 | 1.15 | 3,564 |
| 2008-12-16 | Tanen David M (Director) | Buy | 2,500 | 1.15 | 2,875 |
| 2008-12-15 | Kazam Joshua A (Director) | Buy | 2,500 | 1.05 | 2,625 |
| 2008-12-15 | Tanen David M (Director) | Buy | 2,500 | 1.04 | 2,612 |
| 2008-12-12 | Evans Daron (Chief Financial Officer) | Buy | 4,186 | .97 | 4,081 |
| 2008-12-12 | Strumph Peter M (Chief Executive Officer) | Buy | 3,000 | .90 | 2,685 |
| 2008-12-12 | Kash Peter M (Director) | Buy | 4,000 | 1.23 | 4,900 |
| 2008-12-12 | Kazam Joshua A (Director) | Buy | 4,100 | 1.44 | 5,904 |
| 2008-12-12 | Tanen David M (Director) | Buy | 4,000 | 1.47 | 5,868 |
| 2008-12-11 | Evans Daron (Chief Financial Officer) | Buy | 3,814 | .68 | 2,574 |
| 2008-12-11 | Strumph Peter M (Chief Executive Officer) | Buy | 3,580 | .60 | 2,155 |
| 2008-12-11 | Kash Peter M (Director) | Buy | 600 | .68 | 408 |
| 2008-12-11 | Kazam Joshua A (Director) | Buy | 4,100 | .82 | 3,374 |
| 2008-12-11 | Tanen David M (Director) | Buy | 4,000 | .69 | 2,764 |
| 2008-04-15 | Schafer Gregory W (Director) | Buy | 100 | 4.60 | 459 |
| 2008-04-14 | Evans Daron (Chief Financial Officer) | Buy | 800 | 4.55 | 3,640 |
| 2008-04-14 | Strumph Peter M (Chief Executive Officer) | Buy | 1,400 | 4.70 | 6,580 |
Insider trading activities including stock purchases, stock sales, and option exercises of CAPR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Capricor Therapeutics, Inc. (symbol CAPR, CIK number 1133869) see the Securities and Exchange Commission (SEC) website.